Press Release – Lawsuits Filed Against J&J related to its drug Invokana
Parker Waichman files lawsuits on behalf of two below the knee amputees after the FDA concludes that Johnson & Johnson, Co. and Janssen Pharmaceuticals, Inc.’s sodium-glucose co-transporter-2 (SGLT2) inhibitor diabetes treatment drugs Invokana, Invokamet, and Invokamet XR cause an increased risk of amputations of toes, … [Read more...] about Press Release – Lawsuits Filed Against J&J related to its drug Invokana
Type 2 Diabetes Drugs Associated With Serious Adverse Reactions
Type 2 Diabetes Drugs Serious Adverse Reactions. The personal injury attorneys at Parker Waichman LLP are investigating the association between SGLT2 Type 2 diabetes medications and heart attack, stroke, renal failure, diabetic ketoacidosis, or the need for amputations and are also investigating potential lawsuits. If you … [Read more...] about Type 2 Diabetes Drugs Associated With Serious Adverse Reactions
Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
The Judicial Panel on Multidistrict Litigation established a multidistrict litigation (MDL) in New York to hear claims of diabetic ketoacidosis and kidney damage allegedly caused by the Farxiga and Xigduo diabetes drugs. Farxiga and its sister drug Xigduo XR are manufactured by Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals … [Read more...] about Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
Ohio Man’s Lawsuit Alleges Invokana Responsible for Kidney Failure
Invokana Responsible For A Man's Kidney Failure. Janssen Pharmaceuticals and its parent company Johnson & Johnson are facing a product liability lawsuit that alleges the type 2 diabetes medication is responsible for an Ohio's man kidney failure. Combined with a proper diet and exercise program, Invokana (canaglifozin) is … [Read more...] about Ohio Man’s Lawsuit Alleges Invokana Responsible for Kidney Failure
New Study Shows Increased Risk of Diabetic Ketoacidosis with SGLT2 Drugs
SGLT2 Drugs Increased Risk Of Diabetic Ketoacidosis. Researchers from Brigham and Women's Hospital in Boston say a new class of type diabetes drugs is associated with an increased risk of diabetic ketoacidosis, a serious complication. In 2015, the U.S. Food and Drug Administration (FDA) issued a warning about the … [Read more...] about New Study Shows Increased Risk of Diabetic Ketoacidosis with SGLT2 Drugs
Invokana Associated With A Higher Likelihood of Limb Amputations
FDA Confirms Invokana and Invokamet Lead to Amputations in Some Patients. The United States Food and Drug Administration (FDA) issued a warning to users of the popular Type-2 diabetes drug Invokana and Invokamet (referred to collectively as Invokana) that taking the medication could ultimately lead to amputations of the lower … [Read more...] about Invokana Associated With A Higher Likelihood of Limb Amputations
Invokana Carries Risk of Lower Limb Amputation
Invokana May Increase Risk of Lower Limb Amputations. Regulators in the United Kingdom are warning that Invokana (canagliflozin), a type 2 diabetes medication manufactured by Johnson & Johnson subsidiary Janssen, may carry an increased risk of lower limb amputations. Similar warnings were recently issued by the European Medicines … [Read more...] about Invokana Carries Risk of Lower Limb Amputation
Invokana Diabetes Drug Adds Risk of Amputation Warning
Diabetes Drug Invokana Linked to Heightened Risk of Amputation. The diabetes drug canagliflozin, which is sold under several brand names, including Invokana, Invokamet, and Invokamet XR is now sold with the FDA’s most serious form of warning label, the Black Box Warning. The decision to require the drug’s manufacturers, such as … [Read more...] about Invokana Diabetes Drug Adds Risk of Amputation Warning
Invokana and Other Diabetes Meds Raise Risk of Limb Amputations
Diabetes Meds Raise Risk Of Amputations. According to the European Medicines Agency (EMA), patients with diabetes who take Invokana, or other sodium-glucose cotransporter-2 (SGLT2) inhibitors may have an increased risk of lower limb amputations, especially the toes. Diabetes medications cited include Invokana (canagliflozin), … [Read more...] about Invokana and Other Diabetes Meds Raise Risk of Limb Amputations
Janssen Failed To Disclose Risk Of Ketoacidosis With Invokana
Janssen Failed To Disclose Diabetic Ketoacidosis Risks. A lawsuit has been filed on behalf of a Florida woman who alleges that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to warn about the risk of ketoacidosis with its Type 2 diabetes medication, Invokana. According to court documents, the plaintiff began … [Read more...] about Janssen Failed To Disclose Risk Of Ketoacidosis With Invokana
Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused of failing to warn about the risk of ketoacidosis with its type 2 diabetes drug Invokana. Diabetic ketoacidosis is a serious condition caused by the build up of ketone bodies, leading to acidic blood levels. It can result in a diabetic coma and even death. … [Read more...] about Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges
Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana--Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)--, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, a condition that occurs when too much acid builds up … [Read more...] about Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
Lawsuit Alleges Invokana Caused Stroke
a lawsuit alleging its diabetes drug Invokana caused a stroke The Risky Effect of Invokana Diabetes Drug. Johnson & Johnson, and its subsidiary, Janssen Pharmaceuticals, face a lawsuit alleging its diabetes drug Invokana caused a stroke. The suit was filed in New Jersey on behalf of a plaintiff who began taking the drug in … [Read more...] about Lawsuit Alleges Invokana Caused Stroke
FDA Puts Stronger Warning on Invokana, Invokamet Due to Kidney Risks
The warning labels on four diabetes drugs are being strengthened The Fatal Effect of Invokana. The warning labels on four diabetes drugs are being strengthened due to the risk of acute kidney injury. The U.S. Food and Drug Administration (FDA) is strengthening warnings on canagliflozin, sold under the brand names Invokana … [Read more...] about FDA Puts Stronger Warning on Invokana, Invokamet Due to Kidney Risks
Lawsuit Alleges Invokana Responsible for Diabetic Ketoacidosis Injury
A lawsuit filed against Johnson & Johnson and its subsidiary, Janssen, alleges that the Janssen diabetes medication, Invokana, causes patients to develop diabetic ketoacidosis. The lawsuit was filed in the Court of Common Pleas, Philadelphia County, and includes allegations that the manufacturers of Invokana (canagliflozin) … [Read more...] about Lawsuit Alleges Invokana Responsible for Diabetic Ketoacidosis Injury
Diabetes Drug Invokana Draws FDA Warning for Risk of Bone Fractures
these medications have been shown to increase the risk of bone fractures. Medications Increase Risk Of Bone Fractures In September, the Food and Drug Administration(FDA) published a safety announcement about the type 2 diabetes drugs Invokana and Invokamet (canagliflozin), advising doctors and patients that these medications … [Read more...] about Diabetes Drug Invokana Draws FDA Warning for Risk of Bone Fractures
Invokana Increases Risk of Bone Fractures, FDA Warns
The Food and Drug Administration (FDA) issued a safety announcement in September warning patients and health care providers of an increased risk of bone fractures in patients taking the type 2 diabetes drugs Invokana and Invokamet (canagliflozin). The FDA deemed the new safety announcement necessary because bone fractures have … [Read more...] about Invokana Increases Risk of Bone Fractures, FDA Warns
FDA Warns about Bone Fracture Risks with Invokana
The Food and Drug Administration (FDA) has updated the warning label of the type 2 diabetes drug canagliflozin (Invokana, Invokamet) to warn about the increased risk of bone fractures and reduced bone mineral density for those taking canagliflozin. This warning comes soon after an FDA warning in May in which the agency said … [Read more...] about FDA Warns about Bone Fracture Risks with Invokana
Patients Taking Invokana and Invokamet Face Increased Risk
patients taking Invokana and Invokamet face increased bone fracture risk Fracture Risk Associated With Invokana and Invokamet. Diabetes patients taking the drugs Invokana and Invokamet (canagliflozin) face increased bone fracture risk, the Food and Drug Administration (FDA) warned in a recent safety communication issued last … [Read more...] about Patients Taking Invokana and Invokamet Face Increased Risk
Patients Taking Invokana and Invokamet Face Increased Risk
an increased risk of bone fracture Diabetes Patients Taking Invokana Are Facing Greater Risk. The Food and Drug Administration (FDA) is advising people taking canagliflozin (Invokana, and Invokamet) that they face an increased risk of bone fracture, as reported in their latest study. The FDA has raised the warning on its … [Read more...] about Patients Taking Invokana and Invokamet Face Increased Risk
FDA Warns of Increased Bone Fracture Risk for Diabetes Patients Taking Invokana and Invokamet
Last week, the Food and Drug Administration (FDA) issued a safety communication providing information on bone fracture risk and decreased bone density in patients taking the diabetes drugs Invokana and Invokamet (canagliflozin). The FDA has strengthened the warning for the type 2 diabetes medication canagliflozin (Invokana, … [Read more...] about FDA Warns of Increased Bone Fracture Risk for Diabetes Patients Taking Invokana and Invokamet
